Treatment Centers and Clinical Trials

You can restrict your search to only Treatment Centers or only Clinical Trials by checking the Treatment Center or Clinical Trial checkbox under TYPE. Use the Zoom-In (+ sign on the lower right of the map) to enlarge the map area to find your preferred location. To search for a Treatment Center or Clinical Trial, click on the red map pin for the name of the facility. Click on the name of the facility for more details.

Location

Treatments/Services

Type

Treatment Centers

Calgary Cutaneous Lymphoma Program
Calgary, AB, Canada
Treatment Centers

OhioHealth Physician Group - Hematology/Oncology
Columbus, OH, United States
Treatment Centers

ROCHESTER SKIN LYMPHOMA MEDICAL GROUP, PLLC
Fairport, NY, United States
Treatment Centers

Rush University Medical Center
Chicago, IL, United States
Treatment Centers

The University of Kansas Hospital
Kansas City, KS, United States
Treatment Centers

The Warren Alpert Medical School of Brown University, Department of Dermatology
Providence, RI, United States
Treatment Centers

Fred Hutchinson Cancer Center
Seattle, WA, United States
Treatment Centers

Tulane University School of Medicine
New Orleans, LA, United States
Treatment Centers

University Dermatology Consultants, Inc.
Cincinnati, OH, United States
Treatment Centers

University Hospitals of Cleveland
Cleveland, OH, United States
Treatment Centers

University of Alabama Medical Center
Birmingham, AL, United States
Treatment Centers

University of California, San Francisco
San Francisco, CA, United States
Treatment Centers

University of Iowa Hospitals & Clinics
Iowa City, IA, United States
Treatment Centers

University of North Carolina Medical Center
Chapel Hill, NC, United States
Treatment Centers

University of Pittsburgh Medical Center
Pittsburgh, PA, United States
Treatment Centers

University of Rochester - Wilmot Cancer Institute
Rochester, NY, United States
Treatment Centers

University of Texas Southwestern Medical Center
Dallas, TX, United States
Treatment Centers

University of Virginia-Emily Couric Clinical Cancer Center
Charlottesville, VA, United States
Treatment Centers

University of Wisconsin - Madison
Madison, WI, United States
Treatment Centers

Vanderbilt University Medical Center
Nashville, TN, United States
Treatment Centers

Atrium Health Wake Forest Baptist
Winston-Salem, NC, United States
Treatment Centers

Winship Cancer Institute - Emory University
Atlanta, GA, United States
Treatment Centers

Mayo Clinic - Arizona Campus
Scottsdale, AZ, United States
Treatment Centers

Cleveland Clinic
Cleveland, OH, United States
Treatment Centers

Clinical Cancer Center, Froedtert Hospital
Milwaukee, WI, United States
Treatment Centers

Saint Louis University Cancer Center
St Louis, MO, United States
Treatment Centers

Washington University Medical Center - Siteman Cancer Center
St Louis, MO, United States
Treatment Centers

The Dermatology Clinic at University of Minnesota
Minneapolis, MN, United States
Treatment Centers

Henry Ford Hospital - Cutaneous Lymphoma Program
Detroit, MI, United States
Treatment Centers

University of Michigan Medical Center
Ann Arbor, MI, United States
Treatment Centers

Northwestern Medicine
Chicago, IL, United States
Treatment Centers

University of Chicago
Chicago, IL, United States
Treatment Centers

Yale University School of Medicine
New Haven, CT, United States
Treatment Centers

Penn Cutaneous Lymphoma Program
Philadelphia, PA, United States
Treatment Centers

Jefferson Cutaneous Lymphoma Clinic
Philadelphia, PA, United States
Treatment Centers

Boston Medical Center - Cutaneous Oncology Program
Boston, MA, United States
Treatment Centers

Center for Cutaneous Oncology at Dana Farber/Brigham and Women's Cancer Center
Boston, MA, United States
Treatment Centers

Beth Israel Medical Center
Boston, MA, United States
Treatment Centers

Massachusetts General Hospital Cancer Center
Boston, MA, United States
Treatment Centers

Virginia Commonwealth University Medical Center
Richmond, VA, United States
Treatment Centers

INOVA Melanoma and Skin Oncology Center
Fairfax, VA, United States
Treatment Centers

Dartmouth-Hitchcock Norris Cotton Cancer Center
Lebanon, NH, United States
Treatment Centers

Columbia University Irving Medical Center - Cutaneous Lymphoma Center
New York, NY, United States
Treatment Centers

NYU Grossman School of Medicine
New York, NY, United States
Treatment Centers

University of Texas MD Anderson Cancer Center
Houston, TX, United States
Treatment Centers

Moffitt Cancer Center
Tampa, FL, United States
Treatment Centers

Cleveland Clinic - Indian River Hospital
Vero Beach, FL, United States
Treatment Centers

Miami Cancer Institute BHSF
Miami, FL, United States
Treatment Centers

Levine Cancer Institute
Charlotte, NC, United States
Treatment Centers

Duke Cutaneous T-Cell Lymphoma Clinic and Research Center
Durham, NC, United States
Treatment Centers

UCHealth - University of Colorado Cancer Center - Anschutz
Aurora, CO, United States
Treatment Centers

Huntsman Cancer Institute
Salt Lake City, UT, United States
Treatment Centers

Stanford Medical Center (Multidisciplinary Cutaneous Lymphoma Clinic)
Stanford, CA, United States
Treatment Centers

Oregon Health & Science University (OHSU)
Portland, OR, United States
Treatment Centers

MUSC Cutaneous Lymphoma Clinic
Charleston, SC, United States
Treatment Centers

Johns Hopkins Dermatology
Baltimore, MD, United States
Treatment Centers

OU Physicians
Oklahoma City, OK, United States
Treatment Centers

City of Hope National Medical Center
Duarte, CA, United States
Treatment Centers

Chao Family Comprehensive Cancer Center
Orange, CA, United States
Treatment Centers

Mayo Clinic - Florida
Jacksonville, FL, United States
Treatment Centers

Fondazione IRCCS Ca' Granda
Milan, Italy
Treatment Centers

IU Simon Cancer Center
Indianapolis, IN, United States
Treatment Centers

Peter MacCallum Cancer Centre
Melbourne, Victoria, Australia
Treatment Centers

Westmead Hospital - University of Sydney
Westmead, NSW, Australia
Treatment Centers

Medical University of Graz
Graz, Austria
Treatment Centers

Medical University of Vienna
Vienna, Austria
Treatment Centers

Hôtel-Dieu - CHU de Nantes
Nantes, France
Treatment Centers

Helsinki University Hospital
Helsinki, Finland
Treatment Centers

Hospital Dresden-Friedrichstadt
Dresden, Germany
Treatment Centers

Charité University of Medicine Berlin - Skin Cancer Center
Berlin, Germany
Treatment Centers

Skin Cancer Center - HELIOS Klinikum Krefeld
Krefeld, Germany
Treatment Centers

Rabin Medical Center
Petah-Tikva, Israel
Treatment Centers

Rambam Medical Center
Haifa, Israel
Treatment Centers

Spedali Civili di Brescia
Brescia, Italy
Treatment Centers

Cutaneous Lymphoma Multidisciplinary Clinic - Lisbon
Lisbon, Portugal
Treatment Centers

Friedrich Schiller University - Hospital Jena
Jena, Thuringia, Germany
Treatment Centers

University Medical Centre - Mannheim
Mannheim, Baden-Württemberg, Germany
Treatment Centers

University of Essen - Department of Dermatology
Essen, Germany
Treatment Centers

Semmelweis Medical School
Budapest, Hungary
Treatment Centers

Hospital Universitario 12 de Octubre
Madrid, Spain
Treatment Centers

Cutaneous Lymphoma Clinic - Kimberly and Eric J. Waldman Dept of Dermatology
New York, NY, United States
Treatment Centers

University Hospital Zurich - Department of Dermatology
Zurich, Switzerland
Treatment Centers

Memorial Sloan Kettering Cancer Center
New York, NY, United States
Treatment Centers

John Theurer Cancer Center at HUMC
Hackensack, NJ, United States
Treatment Centers

Emil P. Bisaccia, MD, Center for Photopheresis at Morristown Medical Center
Morristown, NJ, United States
Treatment Centers

Johann Wolfgang Goethe-University Frankfurt
Frankfurt, Germany
Treatment Centers

OSU Comprehensive Cancer Center
Columbus, OH, United States
Treatment Centers

Roswell Park Comprehensive Cancer Center
Buffalo, NY, United States
Treatment Centers

St. Thomas Hospital - St Johns Department of Dermatology
London, United Kingdom
Treatment Centers

UAMS Cancer Center
Little Rock, AR, United States
Treatment Centers

University Dermatology and Skin Cancer Center
Athens, GA, United States
Clinical Trials

Lacutamab - TELLOMAK Study

An open label, multi-cohort, multi-center phase II study evaluating the efficacy and safety of lacutamab (IPH4102) alone or in combination with chemotherapy in patients with advanced t-cell lymphoma


Clinical Trial Name: IPH4102-201 / TELLOMAK study


Clinical Trial Description:

Clinical Trials

TTI-621 - Study

Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides


Brief Summary

Multicenter, open-label, phase 1a/1b trial of TTI-621 in subjects with relapsed or refractory hematologic malignancies and selected solid tumors.


Clinical Trials

Duvelisib and Nivolumab for the Treatment of Stage IIB-IVB MF and SS

Brief Summary:

Clinical Trials

Mogamulizumab Q4week Dosing

Brief Summary:

This is an open-label, multicenter, Phase 2 study to evaluate the safety and tolerability of mogamulizumab given Q4W following initial weekly induction in adult participants with relapsed/refractory MF and SS subtypes of CTCL. The study is composed of a 28-day Screening Period during which participants are screened for entry into this study, followed by a treatment period of up to 2 years from Cycle 1 Day 1.


Clinical Trials

Dose-Escalation Trial Evaluating CPI-818

Brief Summary:

This is a Phase 1/1b, open-label, first in human study of CPI-818, an oral interleukin-2-inducible tyrosine kinase (ITK) inhibitor for the treatment of relapsed/refractory (R/R) T-cell lymphoma.. This trial will study the safety, tolerability, and anti-tumor activity of CPI-818 as a single drug. This trial is composed of dose escalation and dose expansion cohorts.


Clinical Trials

Duvelisib + Nivolumab for the Treatment of MF and SS

Brief Summary:

Clinical Trials

Extracorporeal Photopheresis in Sezary Syndrome (ECP)

Brief Summary:

Clinical Trials

Oral Azacytidine Plus Romidepsin Versus Investigator's Choice in PTCL

Brief Summary:

Clinical Trials

Study of Pembrolizumab Combined With Decitabine and Pralatrexate in PTCL and CTC

Brief Summary:

This is an international, multicenter, multi-arm, phase Ib, model-based dose-escalation study. The primary objectives of the study in each arm is to determine the maximum tolerated dose (MTD), recommended phase 2 dose (RP2D), dose limiting toxicities (DLTs) and to evaluate the clinical efficacy at the MTD of various combinations of pembrolizumab, pralatrexate and decitabine.